Literature DB >> 10522859

Hepatectomy for hepatocellular carcinoma: the surgeon's role in long-term survival.

S T Fan1, I O Ng, R T Poon, C M Lo, C L Liu, J Wong.   

Abstract

HYPOTHESIS: The surgeon can contribute substantially to the long-term survival rate of patients undergoing hepatectomy for hepatocellular carcinoma (HCC).
DESIGN: The long-term survival rate of patients with HCC undergoing hepatectomy has improved, but the contribution of the surgeon to the improved survival rate is unknown. We surveyed 211 consecutive patients undergoing hepatectomy for HCC. The clinical, operative, and pathological factors were analyzed to identify factors that were important in affecting long-term survival.
SETTING: A tertiary referral center. PATIENTS: From April 1989 to December 1995, 211 consecutive patients with HCC underwent 153 major and 58 minor hepatectomies. MAIN OUTCOME MEASURES: Disease-free and overall cumulative survival rate.
RESULTS: The 5-year disease-free survival rate was 27%. By Cox regression analysis, blood transfusion (relative risk [RR], 1.21; 95% confidence interval [CI], 1.05-1.40) and TNM stage (RR, 1.90; 95% CI, 1.47-2.47) were shown to be independent prognostic factors in the 5-year disease-free survival rate. The 5-year overall cumulative survival rate was 37%. By Cox regression analysis, the preoperative indocyanine green retention value at 15 minutes after injection (RR, 1.03; 95% CI, 1.01-1.06), blood transfusion (RR, 1.191; 95% CI, 1.078-1.316), tumor rupture (RR, 1.48; 95% CI, 1.08-2.04), and TNM stage (RR, 1.62; 95% CI, 1.27-2.07) were shown to be significant independent factors that influenced cumulative survival rate.
CONCLUSIONS: The long-term survival of patients with HCC after hepatectomy depends on tumor staging, preoperative hepatic functional reserve, history of blood transfusion, and rupture of HCC. Preoperative liver function and tumor staging cannot be altered; however, the surgeon can play an important role in improving the prognosis if blood transfusion and iatrogenic tumor rupture can be avoided and if function of the liver remnant can be preserved.

Entities:  

Mesh:

Year:  1999        PMID: 10522859     DOI: 10.1001/archsurg.134.10.1124

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  42 in total

1.  Etiology and management of hemmorrhage in spontaneous liver rupture: a report of 70 cases.

Authors:  Zhe-Yu Chen; Qing-Hui Qi; Zuo-Liang Dong
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

2.  A prognostic model and treatment strategy for intrahepatic recurrence of hepatocellular carcinoma after curative resection.

Authors:  Yuzo Umeda; Hiroaki Matsuda; Hiroshi Sadamori; Hiroyoshi Matsukawa; Takahito Yagi; Toshiyoshi Fujiwara
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

3.  Advantage of autologous blood transfusion in surgery for hepatocellular carcinoma.

Authors:  Yoshito Tomimaru; Hidetoshi Eguchi; Shigeru Marubashi; Hiroshi Wada; Shogo Kobayashi; Masahiro Tanemura; Koji Umeshita; Yuichiro Doki; Masaki Mori; Hiroaki Nagano
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

4.  No impact of perioperative blood transfusion on recurrence of hepatocellular carcinoma after hepatectomy.

Authors:  Shintaro Kuroda; Hirotaka Tashiro; Tsuyoshi Kobayashi; Akihiko Oshita; Hironobu Amano; Hideki Ohdan
Journal:  World J Surg       Date:  2012-03       Impact factor: 3.352

Review 5.  Optimizing hepatectomy for hepatocellular carcinoma in Asia-patient selection and special considerations.

Authors:  Clarence Nicholas Kotewall; Tan To Cheung
Journal:  Transl Gastroenterol Hepatol       Date:  2018-10-08

6.  Prognostic impact of anatomic resection for hepatocellular carcinoma.

Authors:  Kiyoshi Hasegawa; Norihiro Kokudo; Hiroshi Imamura; Yutaka Matsuyama; Taku Aoki; Masami Minagawa; Keiji Sano; Yasuhiko Sugawara; Tadatoshi Takayama; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

7.  Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database.

Authors:  Ronnie T Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; Chi Ming Lam; Wai Key Yuen; Chun Yeung; John Wong
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

8.  Treatment strategy for hepatocellular carcinoma: expanding the indications for radiofrequency ablation.

Authors:  Ryosuke Tateishi; Shuichiro Shiina; Takamasa Ohki; Takahisa Sato; Ryota Masuzaki; Jun Imamura; Eriko Goto; Tadashi Goto; Hideo Yoshida; Shuntaro Obi; Shinpei Sato; Fumihiko Kanai; Haruhiko Yoshida; Masao Omata
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

9.  Tumor ablation therapy of liver cancers with an open magnetic resonance imaging-based navigation system.

Authors:  Takashi Maeda; Jaesung Hong; Kozo Konishi; Takanori Nakatsuji; Takefumi Yasunaga; Yo-ichi Yamashita; Akinobu Taketomi; Kazuhiro Kotoh; Munechika Enjoji; Hideaki Nakashima; Kazuo Tanoue; Yoshihiko Maehara; Makoto Hashizume
Journal:  Surg Endosc       Date:  2008-09-24       Impact factor: 4.584

10.  Survival analysis of high-intensity focused ultrasound ablation in patients with small hepatocellular carcinoma.

Authors:  Tan To Cheung; Sheung Tat Fan; Ferdinand S K Chu; Caroline R Jenkins; Kenneth S H Chok; Simon H Y Tsang; Wing Chiu Dai; Albert C Y Chan; See Ching Chan; Thomas C C Yau; Ronnie T P Poon; Chung Mau Lo
Journal:  HPB (Oxford)       Date:  2012-12-04       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.